All Stories

  1. B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets

    Article • Clinical & Experimental Immunology, September 2017, Wiley

    Dr Geraldine Cambridge

  2. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype

    Article • Arthritis & Rheumatology, June 2017, Wiley

    Dr Geraldine Cambridge

  3. Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins

    Article • Arthritis Care & Research, April 2017, Wiley

    Dr Geraldine Cambridge

  4. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study

    Article • Clinical & Experimental Immunology, February 2016, Wiley

    Dr Geraldine Cambridge

  5. Response to Rituximab: Has the Original Hypothesis Been Confirmed?

    Article • Current Pharmaceutical Design, November 2014, Bentham Science Publishers

    Dr Geraldine Cambridge